ID
12250
Description
An open-label, multicenter, randomized, comparative, phase III study to evaluate the efficacy and safety of rituximab plus fludarabine and cyclophosphamide (FCR) versus fludarabine and cyclophosphamide alone (FC) in previously treated patients with CD20 positive B-cell chronic lymphocytic leukemia (CLL). NCT00090051 BO17072
Keywords
Versions (2)
- 10/1/15 10/1/15 -
- 10/28/15 10/28/15 -
Uploaded on
October 28, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
CLL Follow-Up Month 9 BO17072 NCT00090051
Follow-Up Month 9 Chronic Lymphocytic Leukemia NCT00090051 BO17072
Description
Result of Bone marrow examination
Description
Is bone marrow involved with CLL?
Description
Percentage of bone marrow involvement
Data type
integer
Measurement units
- %
Alias
- UMLS CUI [1]
- C1517677
Description
Bone marrow no involvement
Data type
boolean
Alias
- UMLS CUI [1]
- C1517677
Description
Bone marrow uncertain involvement
Data type
boolean
Alias
- UMLS CUI [1]
- C0229654
Description
Tumor assessment
Description
Indicator lesions
Description
Code of origin
Data type
text
Description
extra nodal or other specification
Data type
text
Alias
- UMLS CUI [1]
- C1517067
Description
Side of lesion
Data type
text
Alias
- UMLS CUI [1]
- C0441987
Description
Dimensions
Data type
text
Measurement units
- mm x mm
Alias
- UMLS CUI [1]
- C0439534
Description
Method of assessment
Data type
text
Alias
- UMLS CUI [1]
- C2598110
Description
Other specification
Data type
text
Description
Non-indicator lesions
Description
Code of origin
Data type
integer
Alias
- UMLS CUI [1]
- C0449409
Description
extra nodal or other specification
Data type
text
Alias
- UMLS CUI [1]
- C1517067
Description
Site of lesion
Data type
text
Alias
- UMLS CUI [1]
- C0449685
Description
Present
Data type
boolean
Alias
- UMLS CUI [1]
- C0150312
Description
Liver and spleen examination
Description
Date of Assessment
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1]
- C2985720
Description
Examination type
Data type
integer
Alias
- UMLS CUI [1]
- C0031809
Description
specify other examination
Data type
text
Alias
- UMLS CUI [1]
- C0260879
Description
Hepatomegaly
Data type
boolean
Alias
- UMLS CUI [1]
- C0019209
Description
Splenomegaly
Data type
boolean
Alias
- UMLS CUI [1]
- C0038002
Description
Response assessment
Description
Date of Assessment
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1]
- C2985720
Description
New lesions
Data type
boolean
Alias
- UMLS CUI [1]
- C2986548
Description
Non-indicator lesions
Data type
boolean
Alias
- UMLS CUI [1]
- C3272925
Description
Overall response
Data type
integer
Alias
- UMLS CUI [1]
- C3272903
Description
Complete response
Data type
integer
Alias
- UMLS CUI [1]
- C0677874
Description
Partial response
Data type
integer
Alias
- UMLS CUI [1]
- C1521726
Description
Partial response
Data type
boolean
Alias
- UMLS CUI [1]
- C0741008
- UMLS CUI [2]
- C0040034
Similar models
Follow-Up Month 9 Chronic Lymphocytic Leukemia NCT00090051 BO17072
C0040034 (UMLS CUI [2])